Stocks · News reference

Medifast shares are trading higher after the company reported better-than-expected Q2 financial results.

Aug 3, 2026, 8:41 PMBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

Zacks Investment ResearchSep 17, 2026, 3:17 PMZacks.Com
MNST's International Sales Surge 35%: Is Global Expansion Paying Off?
Monster Beverage's international sales jumped 34.6% to $1.16B in Q2 2026, now representing 46% of total sales. Strong growth in EMEA (27.2%), Asia-Pacific (35.7%), and Latin America (56.1%) is driven by product innovation, cooler placements, and Coca-Cola bottler partnerships. However, lower overseas margins and inflation in aluminum, freight, and fuel pose challenges. The stock trades at a premium 36.59X forward P/E, well above the industry average of 19.32X.
MNST COCO CHEF MED
BenzingaAug 3, 2026, 9:05 PMBenzinga Insights
11 Consumer Staples Stocks Moving In Monday's After-Market Session
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market session. The market value of their outstanding shares is at $108.0 million. The company's, Q2 earnings came out today.
ANDE BRCC DDC EDBL FAMI
BenzingaAug 3, 2026, 8:14 PMBenzinga Newsdesk
Medifast Sees Q3 GAAP EPS $(0.65)-$(0.15) vs $(0.62) Est; Sees Sales $60.000M-$80.000M vs $67.700M Est
Medifast (NYSE:MED) is looking for Q3 GAAP EPS of $(0.65)-$(0.15) vs $(0.62) analyst estimate. sees sales of $60.000 million-$80.000 million vs $67.700 million analyst estimate.
MED